Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
Revision | Operations | |
---|---|---|
07-23-21 by conan.macdougal... | current revision | |
06-24-21 by conan.macdougal... | ||
05-12-21 by [email protected] | ||
05-6-21 by [email protected] | ||
08-12-20 by conan.macdougal... | ||
08-12-20 by conan.macdougal... | ||
08-12-20 by conan.macdougal... | ||
08-12-20 by conan.macdougal... | ||
08-12-20 by conan.macdougal... | ||
07-10-20 by [email protected] | ||
07-7-20 by [email protected] | ||
07-7-20 by [email protected] | ||
04-17-20 by ucsf_admin |
Dosing: Adult Antimicrobial Dosing, Non-dialysis
Indication | CrCl > 50 mL/min | 30 - 50 mL/min | < 30 mL/min |
---|---|---|---|
400 mg IV q12h 500 mg PO BID |
400 mg IV q12h 500 mg PO BID |
400 mg IV q24h 500 mg PO daily |
|
Pseudomonas infections & bloodstream infections |
400 mg IV q8h 750 mg PO q12h |
400 mg IV q12h 500 mg PO q12h |
400 mg IV q24h 500 mg PO daily |
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
Indication |
Intermittent Hemodialysis |
Continuous Hemodialysis |
---|---|---|
All Indications | 400 mg IV qPM or 500 mg PO qPM | 400 mg IV q12h or 500 mg PO q12h |
Dialysis Notes
Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. For detailed view of dialysis dosing and evidence, see Dosing in Hemodialysis document.